Among the enriched pathways, RIG-I-like receptor signaling plays important roles in colon cancer [52]; FoxO signaling pathway has been reported as therapeutic targets in cancer [53]; autophagy was reported as a promising target for CRC [54]; insulin signaling pathway could be a potential CRC therapy [55]. Here, INS is linked to cancer.